REM sleep reduction, mood regulation and remission in untreated depression.

REM sleep reduction, mood regulation and remission in untreated depression. Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

REM sleep reduction, mood regulation and remission in untreated depression. Abstract Text:

The contribution of increased rapid eye movement (REM) pressure through repeated, mild, reduction of (REM) sleep to remission from untreated depression was studied over a 5-month period in 20 depressed and 10 control volunteers. Sixty percent of the depressed subjects were in remission at the end of the study. Sixty-four percent of the variance in remission could be accounted for by four variables: the initial level of self-reported symptoms, the reported diurnal variability in mood, the degree of overnight reduction in depressed mood following interruptions of REM sleep and the quality of dream reports from these awakenings. Increased REM pressure is beneficial for those who are able to construct well-organized dreams.

REM sleep reduction, mood regulation and remission in untreated depression. Publishing Authors By Initials

For similar natural sciences: time: time factors research abstracts see: natural sciences: time: time factors research

PUBMED ID PMID:

MEDLINE DATE:

REM sleep reduction, mood regulation and remission in untreated depression. Journal Published:

PUBLICATION TYPE: Research Support, U.S. Gov't,

Journal: Psychiatry research

VOLUME: 121

Page Numbers: 159-67

Journal Abbreviation: Psychiatry Res

ISSN: 0165-1781

DAY: 1

MONTH: Dec

YEAR: 2003

REM sleep reduction, mood regulation and remission in untreated depression. Information

Number of References:

LANGUAGE: eng

NlmUniqueID: 7911385

REM sleep reduction, mood regulation and remission in untreated depression. Keywords Mesh Terms:

KEYWORDS: Time Factors

MESH TERMS: physiology

Chemical & Substance for Abstract: REM sleep reduction, mood regulation and remission in untreated depression. Information

Substance Name:

Registry Number:

Grant and Affiliation Information for REM sleep reduction, mood regulation and remission in untreated depression.

AFFILIATION: Sleep Disorder Service and Research Center, Rush University Medical Center, 1653 West Congress Parkway, Chicago, IL 60612, USA. rcartwri@rush.edu

Country: Ireland

AGENCY: United States NIMH

GRANT: MH 50471

ACRONYM: MH

MEDLINETA: Psychiatry Res

REFSOURCE:

DATABASENAME:

ACCESSION NUMBER:

Number Hits: 0

REM sleep reduction, mood regulation and remission in untreated depression Related Publications

• A quantitative study of passive anaphylaxis in the guinea pig; the latent period in passive anaphylaxis in its relation to the dose of rabbit antiovalbumin.
• Allergic mechanisms in nervous disease.
• An allosteric rheostat in HIV-1 gp120 reduces CCR5 stoichiometry required for membrane fusion and overcomes diverse entry limitations.
• Development of H activity by human blood-group B substance treated with coffee bean alpha-galactosidase.
• Drug therapy of cerebellar ataxia and disorders of the basal ganglia, based on cerebellar-striatal antagonism.
• Human immunodeficiency virus type 1 Vif functionally interacts with diverse APOBEC3 cytidine deaminases and moves with them between cytoplasmic sites of mRNA metabolism.
• Immunochemical estimation of the rate of disappearance of transfused gamma globulin from the blood in two cases of hypoproteinemia.
• Immunochemical studies on blood groups; the methylpentose contents of hog and human blood group A and O substances and their relationship to cross-reactivity with type XIV antipneumococcus horse serum.
• Permanente Foundation medical bulletin
• Permanente Foundation medical bulletin
• Permanente Foundation medical bulletin
• Pillars Article: An Analysis of the Sequences of the Variable Regions of Bence Jones Proteins and Myeloma Light Chains and their Implications for Antibody Complementarity. J. Exp. Med. 1970. 132: 211-250.
• REM sleep reduction, mood regulation and remission in untreated depression.
• Size and heterogeneity of the combining sites on an antibody molecule.
• Spasticity; its nature and treatment.
• Sterilizing techniques with ethylene oxide.
• Studies on neuromuscular dysfunction; new principles of neuromuscular reeducation.
• The effect of adrenocorticotrophic hormone and X-ray on the amount of circulating antibody.
• The role of drugs in the treatment of cerebral palsy.
• The role of the N-terminal segment of CCR5 in HIV-1 Env-mediated membrane fusion and the mechanism of virus adaptation to CCR5 lacking this segment.
• [Calcium channel blockers in the treatment of arterial hypertension]